Venous Thromboembolism (DVT and PE)

NICE guideline [NG158] Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. Last updated: Aug 2023.

Deep Vein Thrombosis (DVT) Guidelines

If DVT is suspected, calculate the two-level DVT Wells score
 
Clinical feature Points
Active cancer (or within 6 months) 1
Lower limb immobilisation (recent plaster use, paralysis, paresis) 1
Recently bedridden for ≥3 days or major surgery within 12 weeks requiring general or regional anaesthesia 1
Localised tenderness along the distribution of deep venous system 1
Entire leg swollen 1
Calf swelling >3 cm larger than the other leg 1
Pitting oedema confined to the affected leg 1
Collateral superficial veins (non-varicose) 1
Previously documented DVT 1
An alternative diagnosis is at least as likely as DVT -2

Interpretation:
  • Score 2 or more: DVT likely
  • Score 1 or less: DVT unlikely
 

Perform a proximal leg vein ultrasound (with results available within 4 hours)

 

If the ultrasound cannot be done within 4 hours, perform the following:

  • Perform D-dimer test, and
  • Offer interim therapeutic anticoagulation, and
  • Ensure ultrasound is done within 24 hours

Diagnose DVT and start treatment

Perform D-dimer test

  • -ve D-dimer → DVT unlikely, consider alternative diagnosis (stop any interim anticoagulation)
 
  • +ve D-dimer → repeat proximal leg vein ultrasound 6-8 days later
    • Abnormal ultrasound → start treatment
    • Normal ultrasound → consider alternative diagnosis

Perform D-dimer test (with results available within 4 hours):
  • -ve D-dimer → DVT unlikely, consider alternative diagnosis (stop any interim anticoagulation)
  • +ve D-dimer → perform a proximal leg vein ultrasound (with results available within 4 hours)
    • If ultrasound not possible → offer interim therapeutic anticoagulation and ensure ultrasound is done within 24 hours
 

If D-dimer cannot be done within 4 hours → offer interim therapeutic anticoagulation while waiting

This section is identical for DVT and PE

The drug class of choice to treat DVT and PE are anticoagulants.
 

1st line:
  • Apixaban or rivaroxaban

2nd line:
  • Warfarin with  LMWH lead in, or
  • Dabigatran or edoxaban with  LMWH lead in
 

Patient population Recommended drug
Renal failure (creatinine clearance <15 mL/min) Avoid DOACDirect oral anticoagulant, use:
  • LMWHLow molecular weight heparin, or
  • UFHUnfractionated heparin, or
  • Warfarin
Active cancer
  • 1st line: DOACDirect oral anticoagulant
  • 2nd line: LMWHLow molecular weight heparin
Pregnancy DOAC and warfarin are contraindicated, use:
  • LMWHLow molecular weight heparin, or
  • UFHUnfractionated heparin
Anticoagulation contraindicated Consider inferior vena cava filter
Antiphospholipid syndrome (triple positive) Warfarin with LMWH lead in

  • Provoked: 3 months
  • Unprovoked: 6 months
  • Concurrent cancer: 3-6 months

Pulmonary Embolism (PE) Guidelines

If PE is suspected, calculate the two-level PE Wells score
 
Clinical feature Points
Clinical features of DVT (minimum of leg swelling and pain with palpation of the deep veins) 3
An alternative diagnosis is less likely than PE 3
Heart rate >100 bpm 1.5
Immobilisation for >3 days or surgery in the previous 4 weeks 1.5
Previous DVT / PE 1.5
Haemoptysis 1
Active cancer (or within 6 months) 1

Interpretation:
  • Score 5 or more: PE likely
  • Score 4 or less: PE unlikely
 

Perform a CT pulmonary angiogram (CTPA) immediately
  • Abnormal CTPA → diagnose PE and start treatment
  • Normal CTPA
    • If DVT is suspected → consider a proximal leg vein ultrasound scan
    • If DVT is not suspected → PE unlikely, consider alternative diagnosis (stop any interim anticoagulation)
 

If CTPA is not appropriate (allergic to contrast / severe renal impairment - creatinine clearance <30 mL/min / high risk from irradiation)

  • Consider V/Q SPECT or planar scan as an alternative
 

If CTPA / V/Q scan cannot be done immediately → offer interim therapeutic anticoagulation while awaiting CTPA

Perform D-dimer test (with results available within 4 hours):
  • -ve D-dimer → PE unlikely, consider alternative diagnosis (stop any interim anticoagulation)
  • +ve D-dimer → perform CTPA (or V/Q scan) immediately (i.e. follow the above PE likely algorithm)
 

If D-dimer cannot be done within 4 hours → offer interim therapeutic anticoagulation while waiting

Offer:

  • Continuous UFH infusion, and
  • Consider thrombolytic therapy (e.g. alteplase)

This section is identical for DVT and PE

The drug class of choice to treat DVT and PE are anticoagulants.
 

1st line:
  • Apixaban or rivaroxaban

2nd line:
  • Warfarin with  LMWH lead in, or
  • Dabigatran or edoxaban with  LMWH lead in
 

Patient population Recommended drug
Renal failure (creatinine clearance <15 mL/min) Avoid DOACDirect oral anticoagulant, use:
  • LMWHLow molecular weight heparin, or
  • UFHUnfractionated heparin, or
  • Warfarin
Active cancer
  • 1st line: DOACDirect oral anticoagulant
  • 2nd line: LMWHLow molecular weight heparin
Pregnancy DOAC and warfarin are contraindicated, use:
  • LMWHLow molecular weight heparin, or
  • UFHUnfractionated heparin
Anticoagulation contraindicated, or PE happened while on anticoagulation Consider inferior vena cava filter
Antiphospholipid syndrome (triple positive) Warfarin with LMWH lead in

  • Provoked: 3 months
  • Unprovoked: 6 months
  • Concurrent cancer: 3-6 months

References

Author: Chris K
Reviewer:
Last edited: 30/07/25